First Time Loading...
B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 40.54 CNY 3.66% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Betta Pharmaceuticals Co Ltd

Wall Street analysts forecast Betta Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 58.17 CNY with a low forecast of 49.55 CNY and a high forecast of 68.25 CNY.

Lowest Forecast
Wall Street Target
49.55 CNY
22% Upside
Average Forecast
Wall Street Target
58.17 CNY
43% Upside
Highest Forecast
Wall Street Target
68.25 CNY
68% Upside
Lowest
Price Target
49.55 CNY
22% Upside
Average
Price Target
58.17 CNY
43% Upside
Highest
Price Target
68.25 CNY
68% Upside
Betta Pharmaceuticals Co Ltd Competitors:
Price Targets
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
51% Upside
I
ITCI
Intra-Cellular Therapies Inc
25% Upside
SIGA
SIGA Technologies Inc
103% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
6% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
51% Upside
I
ITCI
Intra-Cellular Therapies Inc
25% Upside
SIGA
SIGA Technologies Inc
103% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
6% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
5% Downside
H02
Haw Par Corporation Ltd
73% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
10% Downside
1477
Ocumension Therapeutics
73% Upside

Revenue
Forecast

Revenue Estimate
Betta Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 27%.

16%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Betta Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's operating income is -4%. The projected CAGR for the next 3 years is 60%.

-4%
Past Growth
60%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Betta Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's net income is -7%. The projected CAGR for the next 3 years is 67%.

-7%
Past Growth
67%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Betta Pharmaceuticals Co Ltd's stock price target?
Price Target
58.17 CNY

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 58.17 CNY with a low forecast of 49.55 CNY and a high forecast of 68.25 CNY.

What is Betta Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 27%.

What is Betta Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
60%

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's operating income is -4%. The projected CAGR for the next 3 years is 60%.

What is Betta Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
67%

For the last 8 years the compound annual growth rate for Betta Pharmaceuticals Co Ltd's net income is -7%. The projected CAGR for the next 3 years is 67%.

ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.